{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T07:51:45Z","timestamp":1778917905129,"version":"3.51.4"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T00:00:00Z","timestamp":1519344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"funder":[{"name":"Cleveland Clinic Research Program Committee"},{"name":"Cleveland Clinic Department of Pediatric Gastroenterology"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3,19]]},"DOI":"10.1093\/ibd\/izx077","type":"journal-article","created":{"date-parts":[[2018,2,22]],"date-time":"2018-02-22T22:50:56Z","timestamp":1519339856000},"page":"877-882","source":"Crossref","is-referenced-by-count":7,"title":["Low Indeterminate Rates Associated With Use of the QuantiFERON-TB Gold In-Tube Test in Children With Inflammatory Bowel Disease on Long-term Infliximab"],"prefix":"10.1093","volume":"24","author":[{"given":"Eugene","family":"Vortia","sequence":"first","affiliation":[{"name":"Department of Pediatric Gastroenterology, Cleveland Clinic Foundation, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor E","family":"Uko","sequence":"additional","affiliation":[{"name":"Department of Pediatric Gastroenterology, Cleveland Clinic Foundation, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Belinda","family":"Yen-Lieberman","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology, Cleveland Clinic Foundation, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Frawley","sequence":"additional","affiliation":[{"name":"Department of Pediatric Gastroenterology, Cleveland Clinic Foundation, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E","family":"Worley","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara","family":"Danziger-Isakov","sequence":"additional","affiliation":[{"name":"Infectious Diseases, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Kaplan","sequence":"additional","affiliation":[{"name":"Department of Pediatric Gastroenterology, Cleveland Clinic Foundation, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lori","family":"Mahajan","sequence":"additional","affiliation":[{"name":"Department of Pediatric Gastroenterology, Cleveland Clinic Foundation, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,2,23]]},"reference":[{"key":"key\n\t\t\t\t20180418120449_CIT0001"},{"key":"key\n\t\t\t\t20180418120449_CIT0002","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180418120449_CIT0003","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/art.20009","article-title":"Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy","volume":"50","author":"Wolfe","year":"2004","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20180418120449_CIT0004","doi-asserted-by":"crossref","first-page":"699","DOI":"10.7326\/0003-4819-147-10-200711200-00006","article-title":"Brief communication: characteristics of spontaneous cases of tuberculosis associated with infliximab","volume":"147","author":"Raval","year":"2007","journal-title":"Ann Intern Med"},{"issue":"10","key":"key\n\t\t\t\t20180418120449_CIT0005","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/thx.2005.046797","article-title":"BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment","volume":"60","author":"British Thoracic Society Standards of Care Committee","year":"2005","journal-title":"Thorax"},{"key":"key\n\t\t\t\t20180418120449_CIT0006","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1183\/09031936.00028510","article-title":"The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement","volume":"36","author":"Solovic","year":"2010","journal-title":"Eur Respir J"},{"key":"key\n\t\t\t\t20180418120449_CIT0007","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/art.21043","article-title":"Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists","volume":"52","author":"Carmona","year":"2005","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20180418120449_CIT0008","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","article-title":"An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection","volume":"178","author":"Flynn","year":"1993","journal-title":"J Exp Med"},{"key":"key\n\t\t\t\t20180418120449_CIT0009","first-page":"443","article-title":"Sensitivity and specificity of a gamma interferon blood test for tuberculosis infection","volume":"2","author":"Streeton","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"key":"key\n\t\t\t\t20180418120449_CIT0010","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1378\/chest.08-2575","article-title":"Performance of tests for latent tuberculosis in different groups of immunocompromised patients","volume":"136","author":"Richeldi","year":"2009","journal-title":"Chest"},{"key":"key\n\t\t\t\t20180418120449_CIT0011","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/ibd.21427","article-title":"Factors impacting the results of interferon-\u03b3 release assay and tuberculin skin test in routine screening for latent tuberculosis in patients with inflammatory bowel diseases","volume":"17","author":"Papay","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t20180418120449_CIT0012","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1111\/j.1572-0241.2008.02050.x","article-title":"Comparison of interferon-gamma release assay versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease","volume":"103","author":"Schoepfer","year":"2008","journal-title":"Am j Gastroenterol"},{"key":"key\n\t\t\t\t20180418120449_CIT0013","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1542\/peds.2007-3618","article-title":"Latent tuberculosis diagnosis in children by using the quantiferon-tb gold in-tube test","volume":"123","author":"Lighter","year":"2009","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t20180418120449_CIT0014","doi-asserted-by":"crossref","first-page":"e38556","DOI":"10.1371\/journal.pone.0038556","article-title":"Factors associated with the performance of a blood-based interferon-\u03b3 release assay in diagnosing tuberculosis","volume":"7","author":"Banfield","year":"2012","journal-title":"Plos One"},{"key":"key\n\t\t\t\t20180418120449_CIT0015","first-page":"347","article-title":"t lymphopaenia in relation to body mass index and tnf-alpha in human obesity: adequate weight reduction can be corrective","volume":"54","author":"Tanaka","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t20180418120449_CIT0016","first-page":"81","article-title":"Association of age with the level of response in the quantiferon-tb gold in-tube assay for children with active tuberculosis","volume":"34","author":"Markova","year":"2011","journal-title":"New Microbiol"},{"key":"key\n\t\t\t\t20180418120449_CIT0017","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ibd.21329","article-title":"Quantiferon tb gold testing for tuberculosis screening in an inflammatory bowel disease cohort in the United States","volume":"17","author":"Qumseya","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t20180418120449_CIT0018","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1183\/09031936.00107608","article-title":"Quantiferon-tb gold and the tst are both useful for latent tuberculosis infection screening in autoimmune diseases","volume":"33","author":"Bartalesi","year":"2009","journal-title":"Eur Respir j"},{"key":"key\n\t\t\t\t20180418120449_CIT0019","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1365-2036.2001.00956.x","article-title":"Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn\u2019s disease","volume":"15","author":"Cornillie","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t20180418120449_CIT0020","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1086\/505430","article-title":"Tumor-necrosis-factor blockers: differential effects on mycobacterial immunity","volume":"194","author":"Saliu","year":"2006","journal-title":"j Infect Dis"},{"key":"key\n\t\t\t\t20180418120449_CIT0021","doi-asserted-by":"crossref","first-page":"R114","DOI":"10.1186\/ar1994","article-title":"Inhibition of anti-tuberculosis t-lymphocyte function with tumour necrosis factor antagonists","volume":"8","author":"Hamdi","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"key\n\t\t\t\t20180418120449_CIT0022","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/art.23705","article-title":"Effectiveness of the combination of a whole-blood interferon-gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy","volume":"59","author":"Chen","year":"2008","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20180418120449_CIT0023","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1542-3565(04)00060-6","article-title":"High incidence of anergy in inflammatory bowel disease patients limits the usefulness of ppd screening before infliximab therapy","volume":"2","author":"Mow","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t20180418120449_CIT0024","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1002\/ibd.21605","article-title":"Prednisolone treatment affects the performance of the quantiferon gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection","volume":"17","author":"B\u00e9lard","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t20180418120449_CIT0025","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jaad.2009.12.025","article-title":"Is tuberculin skin testing reliable during anti-tumor necrosis factor-alfa therapy? a case report and review of the literature","volume":"65","author":"Haddican","year":"2011","journal-title":"j Am Acad Dermatol"},{"key":"key\n\t\t\t\t20180418120449_CIT0026","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/1471-2334-10-220","article-title":"Predictors of persistently positive mycobacterium-tuberculosis-specific interferon-gamma responses in the serial testing of health care workers","volume":"10","author":"Ringshausen","year":"2010","journal-title":"bmc Infect Dis"},{"key":"key\n\t\t\t\t20180418120449_CIT0027","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1378\/chest.11-0992","article-title":"Challenges of interferon-\u03b3 release assay conversions in serial testing of health-care workers in a tb control program","volume":"142","author":"Fong","year":"2012","journal-title":"Chest"},{"key":"key\n\t\t\t\t20180418120449_CIT0028","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1093\/cid\/cir792","article-title":"Identification of false-positive quantiferon-tb gold in-tube assays by repeat testing in hiv-infected patients at low risk for tuberculosis","volume":"54","author":"Gray","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180418120449_CIT0029","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1128\/CVI.05058-11","article-title":"Within-subject variability of mycobacterium tuberculosis-specific gamma interferon responses in German health care workers","volume":"18","author":"Ringshausen","year":"2011","journal-title":"Clin Vaccine Immunol"}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ibdjournal\/article-pdf\/24\/4\/877\/24655824\/izx077.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T12:15:21Z","timestamp":1524053721000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/24\/4\/877\/4904056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,23]]},"references-count":29,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,2,23]]},"published-print":{"date-parts":[[2018,3,19]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izx077","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,4]]},"published":{"date-parts":[[2018,2,23]]}}}